Astonea Labs Limited (BSE: 544409)
Health Care · Pharmaceuticals · IN
Rs324.00
-6.09% today · +102.6% 1Y
Astonea Labs Limited (BSE: 544409) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $35.19M.
Over the last twelve months the share price has gained 102.6%, trading between 118.00 and 369.00.
Tweenvest scores Astonea Labs Limited across four factors: quality 54/100, value 35/100, growth 99/100. Its strongest factor is growth.
544409 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $35.19M
- Revenue (TTM)
- $15.74M
- P/E
- 72.19
- EPS
- 4.49
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Rs369.00
- 52-week low
- Rs118.00
- Avg volume (3M)
- —
- Shares outstanding
- 10.51M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Corline Biomedical ABOM: CLBIO | $35.81M | Skr13.70 | 0.00% |
| Nippon Chemiphar Co., Ltd.TSE: 4539 | $35.79M | ¥1,564.00 | -0.57% |
| Beit Jala Pharmaceutical CompanyPLSE: BJP | $35.75M | JD— | — |
| Biomind Labs Inc.OTCPK: BMND.F | $35.68M | $— | — |
| Molecure S.A.WSE: MOC | $35.02M | zł6.61 | -0.75% |
| Prince Pharmaceutical Co., Ltd.TPEX: 6935 | $33.34M | NT$28.50 | +0.18% |
| Navamedic ASAOB: NAVA | $33.34M | Nkr13.30 | -0.37% |
| ImmuPharma plcAIM: IMM | $33.10M | £0.04 | +21.21% |
Figures last refreshed Oct 11, 2026.